Suppliers / MSN Pharmachem

MSN Pharmachem

India Updated 9 July 2026

The public registers hold a second record for MSN Pharmachem. The fuller profile, with 517 active US DMFs and 121 valid CEPs, is at MSN Laboratories. Figures on this page cover only this record.

MSN Pharmachem is an API manufacturer based in India. It holds 94 active US drug master files. Its most recent recorded inspection, by US FDA, closed on 21 April 2023 as VAI. Customs aggregates show $96.9M of exports covering 888 molecules to 62 destinations in 2025.

94
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 21 April 2023 VAI US FDA
  • 18 May 2018 NAI US FDA
  • 13 June 2014 NAI US FDA
  • 5 August 2011 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Sangareddy District, India 3006165229

What they file, and where

Molecule Regulators Docs
Moxifloxacin SFDA (Saudi Arabia), US FDA 7
Aprepitant US FDA 6
Lacosamide SFDA (Saudi Arabia), US FDA 6
Atorvastatin SFDA (Saudi Arabia), US FDA 5
Linagliptin SFDA (Saudi Arabia), US FDA 5
Lurasidone SFDA (Saudi Arabia), US FDA 5
Montelukast SFDA (Saudi Arabia), US FDA 5
Saxagliptin SFDA (Saudi Arabia), US FDA 5
Sitagliptin SFDA (Saudi Arabia), US FDA 5
Sumatriptan SFDA (Saudi Arabia), US FDA 5
Show all 30 molecules on file
Vortioxetine SFDA (Saudi Arabia), US FDA 5
Aripiprazole US FDA 4
Oseltamivir SFDA (Saudi Arabia), US FDA 4
Perindopril US FDA 4
Pregabalin US FDA 4
Rilpivirine US FDA 4
Vilazodone US FDA 4
Vildagliptin SFDA (Saudi Arabia), US FDA 4
Agomelatine US FDA 2
Aripiprazole Lauroxil US FDA 2
Atazanavir US FDA 2
Bisoprolol US FDA 2
Carbinoxamine US FDA 2
Darifenacin US FDA 2
Fesoterodine US FDA 2
Memantine US FDA 2
Milnacipran US FDA 2
Monelukast SFDA (Saudi Arabia) 2
Nebivolol US FDA 2
Ranolazine US FDA 2

Also appears on these molecule pages

Aprepitant API Atazanavir API Bisoprolol API Darifenacin API Fesoterodine API Lacosamide API Linagliptin API Memantine API Milnacipran API Monelukast API Montelukast API Moxifloxacin API
Show 15 more molecule pages
Nebivolol API Oseltamivir API Perindopril API Ranolazine API Rilpivirine API Saxagliptin API Sumatriptan API Vilazodone API Vildagliptin API Vortioxetine API Atorvastatin API Sitagliptin API Pregabalin API Aripiprazole API Lurasidone API

Filings and GMP by regulator

Regulator Filings GMP certificates
CDSCO (India) 1 None

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $21.2M 31
2025 Not reported $96.9M 62
2024 Not reported $86.3M 53
2023 Not reported $70.6M 57

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about MSN Pharmachem

Does MSN Pharmachem hold a US DMF or a CEP?
MSN Pharmachem holds 94 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is MSN Pharmachem FDA-registered?
One site operated by MSN Pharmachem carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did MSN Pharmachem's last inspection go?
The most recent inspection on record closed on 21 April 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 4 inspections are on file.
Where does MSN Pharmachem manufacture?
1 registered site is on record, in India (Sangareddy District). Every site is listed on this page with the register it came from.
What does MSN Pharmachem make?
30 molecules are on record against MSN Pharmachem, including Moxifloxacin, Aprepitant, Lacosamide and Atorvastatin. Each links through to that molecule's full manufacturer list.
Where does MSN Pharmachem file?
Filings are on record with CDSCO (India), 1 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. MSN Pharmachem comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 1 active litigation matter is on record.
  • The most recent inspection outcome was VAI, on 21 April 2023.

Comparable suppliers

Hetero shares 13 molecules Macleods Pharmaceuticals shares 11 molecules Apitoria Pharma shares 10 molecules Dr Reddy's Laboratories shares 10 molecules Matrix Pharmacorp shares 9 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts